很抱歉,您的瀏覽器過於老舊無法閱讀網頁內容的需要,請更新瀏覽器或安裝 Google Chrome.

About Us

Consultants

Daniel D. Von Hoff, M.D., F.A.C.P.

  • Currently the Physician-in-Chief and Distinguished Professor for Translational Research Division at TGen.
  • He is also Chief Scientific Officer for Scottsdale Healthcare’s Clinical Research Institute; and Medical Director of Research at McKesson Specialty Health, and Scientific Medical Officer for US Oncology Research.
  • He holds an appointment as Professor of Medicine, Mayo Clinic, Scottsdale, AZ.
  • Dr. Von Hoff has been involved in developing many new anticancer drugs, and has published extensively.
  • He was appointed to President Bush’s National Cancer Advisory Board from 2004 – 2010, and was the recipient of the 2010 David A. Karnosky Award from the American Society of Clinical Oncology.

Keith Chan, Ph.D

  • Dr. Chan is Senior Advisor at Cornerstone Intellectual Property Foundation in Taiwan, and President of GloboAsia LLC in USA.
  • He is also adjunct professor of National Chengchi University and National Yang Ming University, visiting professor of National Taiwan University, and adjunct research fellow of Beijing University.
  • Dr. Chan is a well-known pharmaceutical scientist and business entrepreneur, has a wide range of business, managerial, regulatory and scientific experience.
  • His experience in new drug development including pre-clinical animal studies, bioanalytical method development, all phases of clinical studies and regulatory submission.
  • His latest accomplishment is leading an Asian pharmaceutical company to complete a new drug development program from start to worldwide market approval. The new drug is now approved and launched in Japan, US, Taiwan and more approvals are expecting.